The advances in the management of patients with Hodgkin lymphoma and non-Hodgkin lymphoma

Updates in bladder, kidney and testes cancer from ASCO 2022

Lung cancer immunotherapy adjuvant and neoadjuvant indications

Axicabtagene ciloleucel provides superior EFS vs standard of care in elderly with relapsed/refractory large B-cell lymphoma

Using combined oral contraceptives may decrease risk of Ovarian, Endometrial and Colorectal cancer

Isatuximab + Kd in RRMM: Depth of Response Results From the IKEMA Trial

Study shows that there is slower cancer drug approval in Europe

Cancer patient symptom and physical function reporting by caregivers used as predictors of adverse clinical outcomes

War in Ukraine: Global cancer aid to support refugees

War in Ukraine: The International Brain Tumour Alliance's response to aiding refugees during the crisis

Ibrutinib plus venetoclax for 1-L treatment of CLL and small lymphocytic lymphoma shows a clinically meaningful PFS

Rucaparib effective as maintenance therapy following first-line platinum-based chemo in ovarian cancer